Brief: Advaxis initiates combination portion of phase 1/2 study with Merck

Procter & Gamble Health

20/10/2016 12:30

Oct 20 (Reuters) - Advaxis Inc  ADXS.O : 
    * Advaxis initiates combination portion of phase 1/2 study 
with Merck 
    * Advaxis Inc says commencement of part B keynote-046 study 
to evaluate keytruda in combination with ADXS-PSA 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nGNXNJTPFa 
Further company coverage:  ADXS.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))